Roswell_Park_Cancer_Institute_Corporation-CR_BARD_INC-2012-10-01T00:00:00.000

RX9360 Davol Pharmaceuticals

New York State - Roswell Park Cancer Institute Corporation · NY, United States

This tender closed on Saturday, September 30, 2023. Browse open opportunities

View Source

Time Left to Bid

Closed

ClosedHealthcare & MedicalProvincial

Basic information

Reference number: Roswell_Park_Cancer_Institute_Corporation-CR_BARD_INC-2012-10-01T00:00:00.000
Issuing organization: New York State - Roswell Park Cancer Institute Corporation · Find award history →
Government level: Provincial
Solicitation type: Healthcare & Medical
Title: RX9360 Davol Pharmaceuticals
Source: NY State Procurement
Source ID: ny-auth-Roswell_Park_Cancer_Institute_Corporation-CR_BARD_INC-2012-10-01T00:00:00.000

Details

Location: NY, United States

Description

RX9360 Davol Pharmaceuticals Vendor: CR BARD INC Authority: Roswell Park Cancer Institute Corporation Type: Commodities/Supplies Award process: Authority Contract - Non-Competitive Bid MWBE: N

Dates

Publication: 2012/10/01 12:00:00 AM UTC
Closing date: 2023/09/30 12:00:00 AM UTC

Estimated value

$51K USD

Classification

Normalized category

Healthcare & Medical

Source: NY State Procurement

Last updated 2026-09-02, 12:11:31 p.m.

Data refreshed every 2 hours